ResMed Stock Rises Following RBC Capital Outperform Rating and Price Target Increase
ResMed (NYSE: RMD) shares are trading higher after RBC Capital Markets upgraded the stock to Outperform. The firm also raised its price target, signaling increased confidence in the company's future…

